Zydus receives final approval from USFDA for Levothyroxine Sodium injection

Zydus receives final approval from USFDA for Levothyroxine Sodium injection

The drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India)

FPJ Web DeskUpdated: Tuesday, March 28, 2023, 10:29 AM IST
article-image
Zydus receives final approval from USFDA for Levothyroxine Sodium injection | Image: Zydus (Representative)

Zydus Lifesciences Limited has received final approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the United States Food and Drug Administration (USFDA), as per an exchange filing.

Levothyroxine Sodium Injection is indicated for the treatment of myxedema coma.

The drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India).

The group now has 354 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.

RECENT STORIES

Modi 3.0 Budget 2024: From ₹401 Crores In 1952-53 To ₹47,65,768 Crores In 2024-25, The Budget...

Modi 3.0 Budget 2024: From ₹401 Crores In 1952-53 To ₹47,65,768 Crores In 2024-25, The Budget...

Stock Market: Sensex Ends Lower Ahead Of Union Budget 2024-25

Stock Market: Sensex Ends Lower Ahead Of Union Budget 2024-25

Maruti Suzuki Grand Vitara Hits 2 Lakh Sales Milestone in India in Under 2 Years

Maruti Suzuki Grand Vitara Hits 2 Lakh Sales Milestone in India in Under 2 Years

Hyundai Alcazar Facelift to Hit the Market Soon: Latest Spy Shots and Updates

Hyundai Alcazar Facelift to Hit the Market Soon: Latest Spy Shots and Updates

YouTube Down: Users Unable To Upload On The Video Sharing Platform

YouTube Down: Users Unable To Upload On The Video Sharing Platform